These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2491597)

  • 41. Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy.
    Arslanian SA; Becker DJ; Rabin B; Atchison R; Eberhardt M; Cavender D; Dorman J; Drash AL
    Diabetes; 1985 Sep; 34(9):926-30. PubMed ID: 3896901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
    Ongagna JC; Levy-Marchal C
    Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complications of mumps infection, islet-cell antibodies, and HLA.
    Mueller-Eckhardt G; Stief T; Otten A; Helmke K; Willems WR; Mueller-Eckhardt C
    Immunobiology; 1984 Oct; 167(4):338-44. PubMed ID: 6392072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Islet cell-specific autoantibodies in children with insulin-dependent diabetes mellitus and their siblings at clinical manifestation of the disease. Childhood Diabetes in Finland Study Group.
    Vähäsalo P; Knip M; Karjalainen J; Tuomilehto-Wolf E; Lounamaa R; Akerblom HK
    Eur J Endocrinol; 1996 Dec; 135(6):689-95. PubMed ID: 9025714
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoantibodies in Indian-Asians with insulin-dependent diabetes in the UK.
    Odugbesan O; Fletcher JA; Sanders A; Bradwell AR; Botazzo GF; Barnett AH
    Postgrad Med J; 1988 May; 64(751):357-60. PubMed ID: 3059339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.
    Whittingham S; Byron SL; Tuomilehto J; Zimmet PZ; Myers MA; Vidgren G; Rowley MJ; Feeney SJ; Koskela P; Tuomilehto-Wolf E; Mackay IR
    Diabet Med; 1997 Aug; 14(8):678-85. PubMed ID: 9272595
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
    Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
    Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes.
    Riley WJ; Maclaren NK; Krischer J; Spillar RP; Silverstein JH; Schatz DA; Schwartz S; Malone J; Shah S; Vadheim C
    N Engl J Med; 1990 Oct; 323(17):1167-72. PubMed ID: 2215594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of the importance of antibodies against islet cells (ICA) and Glutamate Decarboxylase(anti-GAD) for determining prognosis of diabetes type 1 in the Polish population--5 year observation].
    Kretowski A; Szelachowska M; Kinalska I
    Pol Arch Med Wewn; 1999 Apr; 101(4):323-7. PubMed ID: 10740410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes.
    Bonifacio E; Bingley PJ; Shattock M; Dean BM; Dunger D; Gale EA; Bottazzo GF
    Lancet; 1990 Jan; 335(8682):147-9. PubMed ID: 1967440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis.
    Marner B; Lernmark A; Ludvigsson J; MacKay P; Matsuba I; Nerup J; Rabinovitch A
    Diabetes Res; 1985 Sep; 2(5):231-6. PubMed ID: 3905187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CD5+ B lymphocytes in high-risk islet cell antibody-positive and newly diagnosed IDDM subjects.
    Schatz DA; Lang F; Cantor AB; Riley WJ; Maclaren NK; Sleasman JW; Barrett DJ
    Diabetes; 1991 Oct; 40(10):1314-8. PubMed ID: 1718800
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IA-2 antibodies--a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group.
    Savola K; Bonifacio E; Sabbah E; Kulmala P; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Meriläinen J; Akerblom HK; Knip M
    Diabetologia; 1998 Apr; 41(4):424-9. PubMed ID: 9562346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.
    Mustonen A; Knip M; Akerblom HK
    Diabetes; 1983 Aug; 32(8):743-7. PubMed ID: 6347771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity.
    Bonifacio E; Genovese S; Braghi S; Bazzigaluppi E; Lampasona V; Bingley PJ; Rogge L; Pastore MR; Bognetti E; Bottazzo GF
    Diabetologia; 1995 Jul; 38(7):816-22. PubMed ID: 7556984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoantibodies in relation to residual insulin secretion in children with IDDM.
    Ludvigsson J; Hellström S
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):81-9. PubMed ID: 9179462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic, hormonal, and immunological alterations in subjects with antecedent mumps infection.
    Ratzmann KP; Strese J; Rjasanowski I; Witt S; Kohnert KD; Keilacker H; Richter KV; Giebelmann R; Schulz B
    Exp Clin Endocrinol; 1985 Dec; 86(3):323-34. PubMed ID: 3912201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
    Williams AJ; Bingley PJ; Moore WP; Gale EA;
    Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.